Correlation Between Replimune and Karuna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Replimune and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Karuna Therapeutics, you can compare the effects of market volatilities on Replimune and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Karuna Therapeutics.
Diversification Opportunities for Replimune and Karuna Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Replimune and Karuna is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Replimune i.e., Replimune and Karuna Therapeutics go up and down completely randomly.
Pair Corralation between Replimune and Karuna Therapeutics
Given the investment horizon of 90 days Replimune Group is expected to under-perform the Karuna Therapeutics. In addition to that, Replimune is 2.07 times more volatile than Karuna Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Karuna Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 19,935 in Karuna Therapeutics on September 6, 2024 and sell it today you would earn a total of 376.00 from holding Karuna Therapeutics or generate 1.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 30.3% |
Values | Daily Returns |
Replimune Group vs. Karuna Therapeutics
Performance |
Timeline |
Replimune Group |
Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Replimune and Karuna Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Replimune and Karuna Therapeutics
The main advantage of trading using opposite Replimune and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |